The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.
申请公布号
WO2016123391(A1)
申请公布日期
2016.08.04
申请号
WO2016US15450
申请日期
2016.01.28
申请人
GENENTECH, INC.;CONSTELLATION PHARMACEUTICALS, INC.